In solid tumors, including breast cancer, CD133 is generally induced by low oxygen availability via upregulation HIF-1α (Figures 1(b) and 2), even though only in colon cancer cells a physical interaction of HIF-1α with the CD133 promoter was demonstrated [55–58]. The gene discussed is PROM1; the disease is colonic neoplasm.